Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSAIDs and aspirin antiplatelet interaction study
NL-OMON33102Phase 4Active, not recruiting
- Sponsor
- Medisch Spectrum Twente
- Start
- Jun 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of naproxen, ibuprofen, meloxicam, etoricoxib and aspirin in cardiac morbidity (4 arms), sponsored by Medisch Spectrum Twente. Primary endpoint: Difference in closure time. Started Jun 2010; status: active, not recruiting.
02
Drugs
naproxenibuprofenmeloxicametoricoxibaspirin
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on NL-OMON33102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33102.